B Cell Activation, Affinity Maturation, and Immunoglobulin Class Switching

B Cell Receptor Dynamics and Transition to Secretion
  • Immature B Cell Receptors: Immature B cells express surface IgMIgM and IgDIgD as membrane-bound B cell receptors (BCRsBCRs).

  • Secretion Switch: Upon activation, IgDIgD synthesis ceases and B cells exclusively secrete pentameric IgMIgM.

  • mRNA Alternative Processing: Alternative mRNA processing alters the hydrophobic C-terminal tail (membrane anchor) to a hydrophilic C-terminus, releasing secreted IgMIgM into extracellular fluid.

Temporal Course of Infection and IgM Properties
  • Clinical Timeline:

    • Days 00–33: Asymptomatic/early incubation phase.

    • Day 33: Acute symptom onset and initiation of early IgMIgM production.

    • Days 33–66: IgMIgM-mediated response phase.

    • Day 77: Production of high-affinity IgGIgG via affinity maturation leads to symptom resolution.

  • IgM Architecture: Pentameric structure linked by a JJ chain with 1010 antigen-binding sites (5×2=105 \times 2 = 10). High valency provides strong avidity despite early low affinity.

Affinity Maturation and Somatic Hypermutation
  • Hypermutation Mechanism: Activated B cells introduce point mutations into complementarity-determining regions (CDRsCDRs) within variable domains.

  • Clonal Selection: B cells with reduced binding affinity undergo apoptosis, whereas high-affinity mutants are positively selected and expanded.

Class Switching and Heavy Chain Constant Regions
  • Genomic Rearrangement: Site-specific DNA recombination changes the heavy-chain constant region (CHC_H) without altering variable regions (VH/VLV_H/V_L), preserving antigen specificity.

  • Isotype Specialization:

    • IgMIgM: Pentameric; rapid initial response.

    • IgGIgG: Monomeric; dominant high-affinity systemic immunity.

    • IgAIgA: Dimeric (44 binding sites); mucosal protection resistant to proteases and extreme pH.